Suppr超能文献

1型人类免疫缺陷病毒(HIV-1)逆转录酶(RT)的喹喔啉非核苷抑制剂对HIV-1复制的选择性压力导致核苷RT抑制剂特异性(RT Leu-74→Val或Ile以及Val-75→Leu或Ile)HIV-1突变体的出现。

Selective pressure of a quinoxaline nonnucleoside inhibitor of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) on HIV-1 replication results in the emergence of nucleoside RT-inhibitor-specific (RT Leu-74-->Val or Ile and Val-75-->Leu or Ile) HIV-1 mutants.

作者信息

Kleim J P, Rösner M, Winkler I, Paessens A, Kirsch R, Hsiou Y, Arnold E, Riess G

机构信息

Hoechst AG, Frankfurt, Germany.

出版信息

Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):34-8. doi: 10.1073/pnas.93.1.34.

Abstract

The quinoxaline nonnucleoside RT inhibitor (NNRTI) (S)-4-isopropoxycarbonyl-6-methoxy-3-(methylthiomethyl)-3,4- dihydroquinoxaline-2(1H)-thione (HBY 097) was used to select for drug-resistant HIV-1 variants in vitro. The viruses first developed mutations affecting the NNRTI-binding pocket, and five of six strains displayed the RT G190-->E substitution, which is characteristic for HIV-1 resistance against quinoxalines. In one variant, a new mutant (G190-->Q) most likely evolved from preexisting G190-->E mutants. The negative charge introduced by the G190-->E substitution was maintained at that site of the pocket by simultaneous selection for V179-->D together with G190-->Q. After continued exposure to the drug, mutations at positions so far known to be specific for resistance against nucleoside RT inhibitors (NRTIs) (L74-->V/I and V75-->L/I) were consistently detected in all cultures. The inhibitory activities of the cellular conversion product of 2',3'-dideoxyinosine (ddI, didanosine), 2',3'-dideoxyadenosine (ddA) and of 2',3'-didehydro-3'-deoxythymidine (d4T, stavudine) against these late-passage viruses were shown to be enhanced with the L74-->V/I RT mutant virus as compared with the wild-type (wt) HIV-1MN isolate. Clonal analysis proved linkage of the codon 74 and codon 75 mutations to the NNRTI-specific mutations in all RT gene fragments. The nonnucleoside- and nucleoside-resistance mutation sites are separated by approximately 35 A. We propose that the two sites "communicate" through the template-primer which is situated in the DNA-binding cleft between these two sites. Quinoxalines cause high selective pressure on HIV-1 replication in vitro; however, the implication of these findings for the treatment of HIV-1 infection has yet to be determined.

摘要

喹喔啉非核苷逆转录酶抑制剂(NNRTI)(S)-4-异丙氧基羰基-6-甲氧基-3-(甲硫基甲基)-3,4-二氢喹喔啉-2(1H)-硫酮(HBY 097)用于在体外筛选抗药性HIV-1变体。病毒首先发生影响NNRTI结合口袋的突变,六个菌株中有五个显示出RT G190→E替代,这是HIV-1对喹喔啉耐药的特征。在一个变体中,一个新的突变体(G190→Q)很可能是从先前存在的G190→E突变体进化而来的。通过同时选择V179→D和G190→Q,G190→E替代引入的负电荷在口袋的该位点得以维持。在持续接触该药物后,在所有培养物中均持续检测到迄今已知对核苷逆转录酶抑制剂(NRTIs)耐药的特定位置的突变(L74→V/I和V75→L/I)。与野生型(wt)HIV-1MN分离株相比,2',3'-双脱氧肌苷(ddI,去羟肌苷)、2',3'-双脱氧腺苷(ddA)和2',3'-二脱氢-3'-脱氧胸苷(d4T,司他夫定)的细胞转化产物对这些晚期传代病毒的抑制活性在L74→V/I RT突变病毒中增强。克隆分析证明,在所有RT基因片段中,密码子74和密码子75的突变与NNRTI特异性突变相关。非核苷和核苷抗性突变位点相距约35埃。我们提出,这两个位点通过位于这两个位点之间的DNA结合裂隙中的模板引物“通信”。喹喔啉在体外对HIV-1复制产生高选择性压力;然而,这些发现对HIV-1感染治疗的意义尚待确定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f82/40173/5533e7a08d74/pnas01505-0048-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验